Renewal of inclusion on the list of medicines refundable by National Health Insurance and Re-assessment of the actual benefit following the Transparency Committee conclusions in its opinions of 26 November 2008 and reiterated in its opinion of 21 September 2011.
-
Clinical Benefit
Insufficient
The actual benefit of PIASCLEDINE 300 mg capsules is in sufficient to justify reimbursement by National Insurance.
Listen
